Travel Testing
Made Easy
*Patients should confirm their travel requirements prior to purchase
*No-Cost-To-Patient COVID-19 Testing
For insured, uninsured, and undocumented patients*Conditions Apply Find A Location Near Me
Find The Drive-Thru Testing And Collection Site Near You

States that have sites
Don't Get Caught Off Guard

After packing your bags and driving to the airport, the last thing you want to is to be surprised by the airline because your destination requires a Specific Negative COVID-19 Test. Covid Clinic offers a range of COVID-19 Tests that are sure to meet the Travel Requirements of almost every destination.
Available Tests
Patients may be able to receive reimbursement from their health insurance company for all or a portion of their COVID-19 test. Please contact your insurance company for additional information as to whether you may be eligible to receive reimbursement for your COVID-19 test and how to apply. Click Here to see an example of the invoice each patient receives for their test(s).
All tests offered or made available at Covid Clinic’s testing and collection sites are performed by CLIA certified labs and have received an Emergency Use Authorization from the FDA. For more information on what this means, please click the links associated with each test and review the information included in the patient consent form.
Rapid COVID-19 IgG/IgM Antibody Test
This test is used to detect COVID-19 antibodies. A positive antibody test result suggests the patient was recently infected by COVID-19 or has developed an immune response through vaccination.
Results are generally reported within 1 hour at most locations.
The Assure COVID-19 IgG/IgM Rapid Test Device, a test for the qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 (often referred to as COVID-19 or the novel coronavirus) in human venous whole blood (sodium EDTA), serum, plasma (sodium EDTA) and fingerstick whole blood.
The Assure COVID-19 IgG/IgM Rapid Test Device is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. At this time, it is unknown for how long antibodies persist following infection and if the presence of antibodies confers protective immunity
Assure COVID-19 IgG/IgM Rapid Test Device
- IgG: This is the most common antibody. It’s in blood and other body fluids, and protects against bacterial and viral infections. IgG can take time to form after an infection or immunization.
- IgM: Found mainly in blood and lymph fluid, this is the first antibody the body makes when it fights a new infection.
Rapid COVID-19 Antigen Test
- This test is used to rapidly detect an active COVID-19 infection in a patient.
- Results are generally reported within 1 hour at most locations.
Covid Clinic utilizes multiple antigen tests in order to make antigen testing more accessible. The antigen test administered to the patient will be one of three tests, but Covid Clinic is unable to guarantee which of the tests will be utilized for a specific patient.
All of Covid Clinic’s antigen test offerings utilize tests that have received emergency use authorization from the FDA.
For Quidel’s Sofia SARS Antigen FIA Test and Luminostics Clip COVID Rapid Antigen Test, the specimen is collected by a lower nasal swab (anterior nares). The cotton swab does not need to be inserted far into the nose, and is rotated in a circle around the entire inside edge of each nostril at least three times. Results are generally available within 30 minutes and delivered to the patient via email (with the individual’s consent).
For Access Bio’s CareStart COVID-19 Antigen Test, the specimen is collected by a lower nasal swab (anterior nares). Results are generally available within 30 minutes and delivered to the patient via email (with the individual’s consent).
Quidel Corporation Sofia SARS Antigen FIA Test
Access Bio, Inc. CareStart COVID-19 Antigen Test
ACCULA SARS-Cov-2 Test
Test Information
Fact Sheet for Patients
EUA Letter from the FDA
INDICAID COVID-19 Rapid Antigen Test
COVID-19 Antigen + Flu Combo Test
-
Three tests in one! This test is recommended for all individuals and especially those with symptoms.
-
Used to rapidly detect COVID-19, Influenza A, and Influenza B
-
Results are generally reported within 1 hour
Covid Clinic is offering the Quidel Corporation Sofia 2 FLU + SARS Antigen FIA Test. This test has received an emergency use authorization from the FDA.
The specimen is collected by a nasal swab. The cotton swab does not need to be inserted far into the nose, and is rotated in a circle around the entire inside edge of each nostril at least three times. Results are generally available within 30 minutes although result time may vary from location to location.
Rapid COVID-19 Molecular NAAT Test
This test is used to rapidly detect an active COVID-19 infection in a patient.
Results are generally reported within 1 hour
Covid Clinic, Inc. is offering the Abbott ID Now COVID-19 Assay performed on the ID NOW Instrument. This test is a rapid molecular in vitro diagnostic test utilizing an isothermal nucleic acid amplification technology intended for the qualitative detection of nucleic acid from the SARS-CoV-2 viral RNA in direct nasal swabs. The ID Now COVID-19 Assay has received Emergency Use Authorization (EUA) from the FDA.
Many travel restrictions require a molecular or NAAT test be conducted prior to arrival. Abbott’s ID Now COVID-19 test may satisfy these requirements; however, it is the purchaser’s responsibility to verify the test will be accepted for travel prior to purchase.
Abbott ID Now COVID-19 Assay
Rapid RT-PCR COVID-19 Test
-
Results are generally reported within 2 hour
-
Satisfies most travel restriction requirements
-
Collected by anterior nares nasal swab (front of the nose only).
-
Some travel destinations do not accept test results with an anterior nares collection method. Patients should confirm this test is acceptable for their travel requirements prior to purchase.
The Rapid RT-PCR COVID-19 Test is a molecular, in vitro diagnostic test utilizing end point reverse transcriptase polymerase chain reaction (RT-PCR) and lateral flow technologies for the qualitative, visual detection of the coronavirus SARS-CoV-2 viral RNA. The four steps utilized to perform the test are lysis of the virus, reverse transcription of viral RNA to cDNA, nucleic acid amplification, and detection.
The Rapid RT-PCR COVID-19 Test has been released under FDA Emergency Use Authorization (EUA) for the detection of nucleic acid from SARS-CoV-2 (the virus responsible for COVID-19 infection), and can be used in applications that require molecular/ RT-PCR testing. Please consult your state health department for additional information regarding specific uses (such as pre and post travel requirements). Many travel restrictions require a RT-PRC, molecular, or NAAT test be conducted prior to arrival at the destination. The Rapid RT-PCR COVID-19 test satisfies most travel requirements; however, it is the purchaser’s responsibility to verify the test will be accepted for travel prior to purchase.
ACCULA SARS-Cov-2 Test
Expedited RT-PCR COVID-19 Test
Expedited Results – as fast as 1 day, see your location’s website for details
Satisfies most travel restriction requirements
Can be collected by nasal mid-turbinate or nasopharyngeal swab.
The RT-PCR COVID-19 Test has been released under FDA Emergency Use Authorization (EUA) for the detection of nucleic acid from SARS-CoV-2 (the virus responsible for COVID-19 infection), and can be used in applications that require molecular/ RT-PCR testing. Please consult your state health department for additional information regarding specific uses (such as pre and post travel requirements). This test is an RT-PCR, molecular and NAAT test which satisfies most travel requirements; however, it is the purchaser’s responsibility to verify the test will be accepted for travel prior to purchase. Please note that most travel restrictions require that a traveler’s test specimen IS COLLECTED within 72 hours prior to arrival at a destination.
The price for the Expedited RT-PCR COVID-19 Test Service includes payment for medical oversight, collection site infrastructure, performance of sample collection, information systems, result reporting, result delivery, other ancillary services or costs incurred by COVID Clinic including the $75 charge to COVID Clinic from Medlab2020, Inc., the laboratory that processes the test. Medlab2020, Inc.’s primary address is 1594 N Main St, Orange, CA 92867.
One of the following tests will be utilitized for the Expedited RT-PCR COVID-19 Test:
DiaCarta QuantiVirus SARS-CoV-2 Multiplex Test Kit
Quidel Lyra Direct SARS-CoV-2 Assay
Bioeksen Bio-Speedy Direct RT-QPCR SARS-CoV-2
Amplitude Solution with the TaqPath COVID-19 High-Throughput Combo Kit
Respiratory Pathogen Panel
The BioFire Respiratory Panel 2.1 (RP2.1) is a PCR-based multiplexed nucleic acid test intended for use with the BioFire® FilmArray® 2.0 or BioFire® FilmArray® Torch Systems for the simultaneous qualitative detection and identification of multiple
respiratory viral and bacterial nucleic acids in nasopharyngeal swabs (NPS) obtained from individuals suspected of respiratory tract infections, including COVID-19.
The following organism types and subtypes are identified using the Respiratory Pathogen Panel:
Viruses | Bacteria |
---|---|
Adenovirus | Bordetella parapertussis |
Coronavirus 229E | Bordetella pertussis |
Coronavirus HKU1 | Chlamydia pneumoniae |
Coronavirus NL63 | Mycoplasma pneumoniae |
Coronavirus OC43 | |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | |
Human Metapneumovirus | |
Human Rhinovirus/Enterovirus | |
Influenza A, including subtypes H1, H3 and H1-2009 | |
Influenza B | |
Parainfluenza Virus 1 | |
Parainfluenza Virus 2 | |
Parainfluenza Virus 3 | |
Parainfluenza Virus 4 | |
Respiratory Syncytial Virus |